A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors.

F.E. Stuurman; M.P.J.K. Lolkema; A.D. Huitema; P.M. Soetekouw; H. Rosing; H. Rolfe; P. Kaur; J.H. Beijnen; H. van Tinteren; E.E. Voest; J.H.M. Schellens

doi:10.1002/jcph.108.

A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors.

Translated title of the contribution: A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors.

F.E. Stuurman
, M.P.J.K. Lolkema
, A.D. Huitema
, P.M. Soetekouw
, H. Rosing
, H. Rolfe
, P. Kaur
, J.H. Beijnen
, H. van Tinteren
, E.E. Voest
, J.H.M. Schellens

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors.
Original language	Undefined/Unknown
Pages (from-to)	878-883
Number of pages	6
Journal	Journal of Clinical Pharmacology
Volume	53
Issue number	8
DOIs	https://doi.org/10.1002/jcph.108.
Publication status	Published - 2013

Access to Document

10.1002/jcph.108.

Cite this

Stuurman, F. E., Lolkema, M. P. J. K., Huitema, A. D., Soetekouw, P. M., Rosing, H., Rolfe, H., Kaur, P., Beijnen, J. H., van Tinteren, H., Voest, E. E., & Schellens, J. H. M. (2013). A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors. Journal of Clinical Pharmacology, 53(8), 878-883. https://doi.org/10.1002/jcph.108.

@article{63fde7a5085f4acfb236b1d39d7d931a,

title = "A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors.",

author = "F.E. Stuurman and M.P.J.K. Lolkema and A.D. Huitema and P.M. Soetekouw and H. Rosing and H. Rolfe and P. Kaur and J.H. Beijnen and \{van Tinteren\}, H. and E.E. Voest and J.H.M. Schellens",

year = "2013",

doi = "10.1002/jcph.108.",

language = "Undefined/Unknown",

volume = "53",

pages = "878--883",

journal = "Journal of Clinical Pharmacology",

issn = "0091-2700",

publisher = "Wiley-Blackwell",

number = "8",

}

Stuurman, FE, Lolkema, MPJK, Huitema, AD, Soetekouw, PM, Rosing, H, Rolfe, H, Kaur, P, Beijnen, JH, van Tinteren, H, Voest, EE & Schellens, JHM 2013, 'A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors.', Journal of Clinical Pharmacology, vol. 53, no. 8, pp. 878-883. https://doi.org/10.1002/jcph.108.

TY - JOUR

T1 - A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors.

AU - Stuurman, F.E.

AU - Lolkema, M.P.J.K.

AU - Huitema, A.D.

AU - Soetekouw, P.M.

AU - Rosing, H.

AU - Rolfe, H.

AU - Kaur, P.

AU - Beijnen, J.H.

AU - van Tinteren, H.

AU - Voest, E.E.

AU - Schellens, J.H.M.

PY - 2013

Y1 - 2013

U2 - 10.1002/jcph.108.

DO - 10.1002/jcph.108.

M3 - Article

SN - 0091-2700

VL - 53

SP - 878

EP - 883

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

IS - 8

ER -